140 related articles for article (PubMed ID: 35907186)
1. Cost-effectiveness analysis of radiosurgical capsulotomy versus treatment as usual for treatment-resistant obsessive-compulsive disorder.
Najera RA; Gregory ST; Shofty B; Anand A; Gadot R; Youngerman BE; Storch EA; Goodman WK; Sheth SA
J Neurosurg; 2023 Feb; 138(2):347-357. PubMed ID: 35907186
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and threshold analysis of deep brain stimulation vs. treatment-as-usual for treatment-resistant depression.
Kabotyanski KE; Najera RA; Banks GP; Sharma H; Provenza NR; Hayden BY; Mathew SJ; Sheth SA
Transl Psychiatry; 2024 Jun; 14(1):243. PubMed ID: 38849334
[TBL] [Abstract][Full Text] [Related]
3. MR-Guided Focused Ultrasound Versus Radiofrequency Capsulotomy for Treatment-Refractory Obsessive-Compulsive Disorder: A Cost-Effectiveness Threshold Analysis.
Kumar KK; Bhati MT; Ravikumar VK; Ghanouni P; Stein SC; Halpern CH
Front Neurosci; 2019; 13():66. PubMed ID: 30792625
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of deep brain stimulation for patients with treatment-resistant obsessive-compulsive disorder.
Moon W; Kim SN; Park S; Paek SH; Kwon JS
Medicine (Baltimore); 2017 Jul; 96(27):e7397. PubMed ID: 28682894
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases.
Lester-Coll NH; Dosoretz AP; Magnuson WJ; Laurans MS; Chiang VL; Yu JB
J Neurosurg; 2016 Dec; 125(Suppl 1):18-25. PubMed ID: 27903191
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness Analysis of Stereotactic Radiosurgery Alone Versus Stereotactic Radiosurgery with Upfront Whole Brain Radiation Therapy for Brain Metastases.
Kim H; Rajagopalan MS; Beriwal S; Smith KJ
Clin Oncol (R Coll Radiol); 2017 Oct; 29(10):e157-e164. PubMed ID: 28552517
[TBL] [Abstract][Full Text] [Related]
7. Results of Gamma Knife anterior capsulotomy for refractory obsessive-compulsive disorder: results in a series of 10 consecutive patients.
Spatola G; Martinez-Alvarez R; Martínez-Moreno N; Rey G; Linera J; Rios-Lago M; Sanz M; Gutiérrez J; Vidal P; Richieri R; Régis J
J Neurosurg; 2018 Sep; 131(2):376-383. PubMed ID: 30215566
[TBL] [Abstract][Full Text] [Related]
8. Dorsal anterior cingulotomy and anterior capsulotomy for severe, refractory obsessive-compulsive disorder: a systematic review of observational studies.
Brown LT; Mikell CB; Youngerman BE; Zhang Y; McKhann GM; Sheth SA
J Neurosurg; 2016 Jan; 124(1):77-89. PubMed ID: 26252455
[TBL] [Abstract][Full Text] [Related]
9. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of deep brain stimulation versus treatment as usual for obsessive-compulsive disorder.
Ooms P; Blankers M; Figee M; Bergfeld IO; van den Munckhof P; Schuurman PR; Denys D
Brain Stimul; 2017; 10(4):836-842. PubMed ID: 28457837
[TBL] [Abstract][Full Text] [Related]
11. Economic Evaluation of Digital Therapeutic Care Apps for Unsupervised Treatment of Low Back Pain: Monte Carlo Simulation.
Lewkowicz D; Bottinger E; Siegel M
JMIR Mhealth Uhealth; 2023 Jun; 11():e44585. PubMed ID: 37384379
[TBL] [Abstract][Full Text] [Related]
12. Benefits of stereotactic radiosurgical anterior capsulotomy for obsessive-compulsive disorder: a meta-analysis.
Gupta R; Chen JW; Hughes NC; Hamo M; Jean-Baptiste S; Paulo DL; Chanbour H; Fan R; Ye F; Vadali A; Cmelak A; Bick SK
J Neurosurg; 2024 Mar; ():1-12. PubMed ID: 38552242
[TBL] [Abstract][Full Text] [Related]
13. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Deep Brain Stimulation in Treatment-Resistant Obsessive-Compulsive Disorder: Outcome and Quality of Life at Four to Eight Years Follow-Up.
Winter L; Saryyeva A; Schwabe K; Heissler HE; Runge J; Alam M; Heitland I; Kahl KG; Krauss JK
Neuromodulation; 2021 Feb; 24(2):324-330. PubMed ID: 32667114
[TBL] [Abstract][Full Text] [Related]
15. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
17. Deep brain stimulation versus anterior capsulotomy for obsessive-compulsive disorder: a review of the literature.
Pepper J; Hariz M; Zrinzo L
J Neurosurg; 2015 May; 122(5):1028-37. PubMed ID: 25635480
[TBL] [Abstract][Full Text] [Related]
18. Tractography-Guided Anterior Capsulotomy for Major Depression and Obsessive-Compulsive Disorder: Targeting the Emotion Network.
Avecillas-Chasin JM; Hurwitz TA; Bogod NM; Honey CR
Oper Neurosurg (Hagerstown); 2021 Mar; 20(4):406-412. PubMed ID: 33475697
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of surgical resection and cesium-131 intraoperative brachytherapy versus surgical resection and stereotactic radiosurgery in the treatment of metastatic brain tumors.
Wernicke AG; Yondorf MZ; Parashar B; Nori D; Clifford Chao KS; Boockvar JA; Pannullo S; Stieg P; Schwartz TH
J Neurooncol; 2016 Mar; 127(1):145-53. PubMed ID: 26725100
[TBL] [Abstract][Full Text] [Related]
20. Gamma Knife capsulotomy for correction of obsessive-compulsive symptoms in a patient with schizophrenia: Case report.
Galkin MV; Zaitsev OS; Golanov AV; Mosolov SN; Tomskiy AA; Poddubskaya AA; Kostjuchenko VV
Prog Brain Res; 2022; 272(1):23-31. PubMed ID: 35667804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
